2025 Speakers

Peter Aaby I am originally trained as a social anthropologist. Since 1978 I have built a large health and demographic surveillance system (HDSS) in Guinea-Bissau. In 1978, under-5 child mortality was 500/1000. Contrary to all expectations, the high case fatality in measles infection (21%) was not...

Dr. Rajeshwari Adhiseshan is a Senior Program Officer at the Bill & Melinda Gates Foundation, where she plays a pivotal role in global health initiatives, particularly in the vaccine development sector. With a robust background in pharmacy and a PhD from Pune University, Dr. Rajeshwari has...

Dr. Babita Agrawal is a Professor in the Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. She completed M.Sc. in Biochemistry and PhD in Immunology. After completing post-doctoral training, she joined a Canadian biotech company, working on...

Cristina Alaimo is a microbiologist with over 20 years of experience in the biotechnology industry and vaccine development. As Head of Clinical and Regulatory, Cristina is responsible for LimmaTech Biologics’ clinical trials, to advance innovative vaccine candidates from preclinical stages into...

Damian Álvarez Paggi is Co-Founder & CEO of Eureka Nanobioengineering, a Buenos Aires–based biotech innovator. He is a scientist, entrepreneur, professor, and communicator with over 15 years of leadership in academic research, R&D, and biotech ventures. He holds a PhD in Biophysical...

Jean-Pierre is a Pharmacist with a PhD in Pharmaceutical Engineering and has broad biopharmaceutical knowledge on vaccine development ranging from lead immunology, process technology, product characterization, quality and regulatory affairs till technology transfer and business development. He has...

I am a biochemist by training, with a strong research background in structural biology and its application to translational research. Over the course of my PhD and Postdoctoral training, I acquired comprehensive technical knowledge of nuclear magnetic resonance (NMR), x-ray crystallography and...

Louis Ates is the preclinical lead of tuberculosis vaccine development at BioNTech (Mainz, Germany). This includes (preclinical) portfolio management of BNT164a1 and BNT164b1 candidates, which are currently in clinical trials. His main role is to shape research and development to translate the...

Kabeer Aziz is an investor with over a decade of experience at the intersection of finance and life sciences. With a passion for global health research & development, Kabeer co-founded Adjuvant Capital, a life sciences investment fund designed to accelerate the development of new technologies...

Dr. Ali Azizi has extensive experience in vaccine development and clinical/analytical immunoassays. He has successfully led and managed numerous international biotechnology and vaccine projects, guiding them from pre-clinical research through to PhaseIII trials. Dr. Azizi currently serves as a...

Dr. Irnela Bajrovic-Jasarevic specializes in advancing pharmaceutical technologies and biopharmaceutical development. She earned her PhD in pharmaceutical sciences from the University of Texas at Austin, where her research demonstrated the viability of Jurata's thin film formulation as a...

Dr. Sanjib Banerjee, currently serving as Chief Operating Officer of Veeda Lifesciences (Biopharma), has successfully established Veeda’s Biopharma Lab and other resources in Bengaluru (India). The Biopharma division of Veeda is catering global clientele as a Centre of Excellence for their...

Dr. Jane M Barratt, is an internationally recognized advisor and non-executive leader with extensive experience in global ageing, health, and social policy.  She serves on multiple international boards and committees, bringing expertise in governance, strategic planning, and interdisciplinary...

Daniel Becker is responsible for Business Development of the eFIT platform at KyooBe Tech GmbH, focusing on innovative electron irradiation technologies for pathogen inactivation. With a background in biotechnology and process engineering, he has extensive experience in vaccine process...

Christine Stabell Benn, MD, PhD, DMSc, MAE, has worked at the Health and Demographic Surveillance System (HDSS) site Bandim Health Project in Guinea-Bissau (www.bandim.org) since 1993. Dr Benn holds a position as a Professor of Global Health at University of Southern Denmark. She is also a Chair at ...

Hamilton Bennett (she/her) is the Executive Director of Health Security R&D and Partnerships at Moderna. In this role, Hamilton is responsible for the Global Public Health and Medical Countermeasures portfolio, driving collaborative research and development with a broad range of government and...

My research, funded by UK Medical Research Council fellowships (Career Development Award: 2019 – 2024; and Senior Fellowship: 2024 - 2029) and US National Institute of Health grants, focuses on next-generation vaccines against major bacterial pathogens. Using the chief causes of bacterial...

Cedric Bogaert cofounded myNEO, whose software uses neural networks trained on biological datasets to figure out the best personalized cancer immunotherapies for a given patient. myNEO focuses on neoantigen targets it identifies from the genomic profile of the tumor sample. Based on promising...

Luigi Bonfatti is Executive Advisor at RVMC (Regionalized Vaccine Manufacturing Collaborative). As member of RVMC Leadership he has global accountability on industry (and industry associations) engagement as well as for Asia regionalization agenda. Before joining RVMC, Luigi has been supporting...

Dr. Maria Elena Bottazzi is an internationally recognized tropical and emerging disease vaccinologist, global health advocate and cocreator of a patent-free, open science COVID-19 vaccine technology that led to the development of Corbevax in India and IndoVac in Indonesia, and with approximately...

Professor Yap Boum II, currently serving as the Deputy Incident Manager for the Continental Mpox response for Africa CDC. He is the former Executive Director of the Institute Pasteur of Bangui in the Central African Republic, is a distinguished figure in the field of public health. In this role, he ...

With over 25 years of experience in the biopharmaceutical industry, Martine brings deep expertise in protein sciences, including molecular biology, recombinant protein expression, purification, and biophysical characterization. Her work has contributed to the development of robust immunological...

Moy Bracken is an experienced healthcare professional currently serving as the Research Unit Manager, Research Lead R&D, and Market Access Researcher at the Access to Medicine Foundation since May 2021. Prior to this, Moy worked as a freelance Community and Hospital Pharmacist at Pharmaconex...

Dr Gabrielle Breugelmans is the Director of Epidemiology and Data Science at the Coalition for Epidemic Preparedness Innovations (CEPI). The Mission of the Epidemiology and Data Science department is to advance CEPI’s goals by generating and translating critical epidemiological and data science...

Tom Brown is a recognised leader in global health procurement and supply chain management with more than 25 years of experience. He is the Owner and Director of Supply Chain Matters Ltd, a consulting firm providing advisory services to global health funders and implementing partners. Tom has held...

Dr. Luigi Buonaguro is the Director of the Innovative Immunological Models at the National Cancer Institute - IRCCS “Pascale ”, Naples – Italy. He is an expert in identification and characterization of tumor antigens for preventive/therapeutic cancer vaccine development. His focus is mostly on...

Dr. Nicolas Burdin serves as Global Head of R&D at Clover. Dr. Burdin has spent over 27 years in vaccine research and development (R&D) with increasing responsibility roles at Sanofi, contributing to the successful progression of multiple prophylactic and therapeutic projects against...

Dr. David Burkhart is the Chief Executive Officer and a Co-Founder of Inimmune. A passionate, direct and results oriented team leader, he strives to bring out the best in people by inspiring them to realize their untapped potential. Dr. Burkhart brings nearly 20 years of experience in the...

Director of the Division of Communicable Diseases, Environment and Health Robb Butler is a behavioural scientist with over 25 years of international experience working in public health, social protection, and humanitarian assistance. After 17 years working on health and development programmes in...

Ed spent more than 20 years in large pharma (Pfizer, AstraZeneca) and biotech (Scriptgen/Anadys Pharmaceuticals), focussing on both therapeutic and preventive approaches to infections caused by viruses, bacteria and fungi. Over the years his responsibilities increased from bench scientist to...

Dr. Jacob Cain is a developmental biologist by training whose work has focused on the development, manufacture, and testing of genetic medicines to treat rare disease.  He has supported product life cycles from early development, pre-clinical and IND stages, through to commercial readiness and BLA...

Dr. Caldwell is the Associate Vice President, Vaccine Research & Education at Meharry Medical College in Nashville TN.  He is Professor of Global Public Health, Biomedical Sciences and serves as Program Director for the newly revived Master of Science in Clinical Investigation (MSCI) degree...

Expert with over 20 years in CMC activities spanning pre-clinical, early & late stage clinical development, formulation, analytical development, fill/finish process and manufacturing of peptide, protein, antibody, vaccines, viral vectors, cell and gene therapy. Enthusiast for...

Dr Federica Cappuccini is a Senior Scientist in the Laboratory Research and Innovations (LRI) department at CEPI, with extensive expertise in vaccine development, immunology, and translational research. She leads preclinical support across CEPI’s RNA programme and innovation portfolios, reviewing...

Sabrina is a Biologist with a PhD in Biotechnology and Molecular Biology. With over 15 years of experience in research and development, she currently leads the veterinary vaccine development area, mainly focused on Foot-and-Mouth Disease. She has extensive experience in managing scientific...

Andrew first studied as a virologist at the University of Warwick before then furthering his education with postgraduate studies for his DPhil in influenza replication at Oxford University. Since then he has applied his scientific knowledge in a commercial setting. After working as part of a...

Marco Cavaleri is the Head of Public Health Threats at the European Medicines Agency (EMA). He leads EMA activities on emerging pathogens, vaccines, and antimicrobial resistance, and previously chaired the EMA’s COVID-19 Taskforce. With extensive experience in both industry and regulatory roles, he ...

Professor Lucy Chappell is Chief Scientific Adviser to the Department of Health and Social Care and Chief Executive Officer of the National Institute for Health and Care Research (NIHR), the UK’s largest funder of health and care research. The Chief Scientific Adviser has overall responsibility for ...

Johannes Charlier (DVM, PhD, Dip. EVPC) is a veterinary scientist and founding manager of the animal health research & consulting agency Kreavet. He founded Kreavet in 2017  to support organisations in the development of sustainable animal health solutions through research, impact assessments...

Dr. Kundai Chinyenze is a physician with over 23 years of experience in vaccine and biomedical prevention research and development (R&D), as well as in strengthening R&D and healthcare delivery capacity across East and Southern Africa. She currently serves as Strategic Partnerships and...

Fabrizio Chiodo studies adaptive and innate responses of non-mammalian glyco-conjugates, mostly in the context of vaccines and host-pathogen interactions. During his PhD (defended in 2013, San Sebastian, Spain), working on a new generation of vaccines technology he had a long stay at the Amsterdam...

Dr. Christensen was recently appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career, his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery...

Ivo Claassen is the head of Veterinary Medicines Division at the European Medicines Agency. He has over 35 years of experience in multiple roles in vaccine production, QC/QA, R&D and regulatory affairs, both for human and veterinary medicinal products. He has worked internationally on capacity...

Pär Comstedt, PhD, is Vice President of Infectious Disease Vaccines at Evaxion. He leads the company’s portfolio of bacterial and viral vaccine programs, developed through the proprietary AI-immunology platform. With 20 years of experience in vaccine R&D, Pär has contributed across...

I have an interest in understanding the immunological mechanisms that underlie the success or failure of vaccines developed to induce T-cell responses in livestock species. This has predominantly focused on Theileria parva but I also have interests in other major pathogens including Mycobacterium...

Dr. Cooke is CEO of Omniose.  He has over thirty years of experience in the biopharmaceutical industry with a focus on vaccines.  He was previously CEO of NovaDigm Therapeutics, CEO of Mojave Therapeutics, COO at AVANT Immunotherapeutics, and SVP at Ology Bioservices. Prior to his leadership roles...

Dr Jakob Peter Cramer is a medical doctor specialised in internal medicine, tropical medicine, travel medicine and infectious diseases. He joined the Coalition for Epidemic Preparedness Innovations (CEPI) as Director of Clinical Development in June 2019. Prior to his role at CEPI, Jakob was Head...

James F. Cummings, M.D., FACP, FIDSA, FASTMH  has served as Chief Medical Officer at Vaxart since August 2021 and is responsible for all clinical vaccine development.. Preceding his role at VAXART, Dr. Cummings served as President of ICON Government and Public Health Solutions, Inc., a global...

Director Formulation Platform at CureVac SE Holds a PhD degree in Drug delivery and Nanomedicines from the Ghent University. Currently leading discovery formulation activities within CureVac (Tubingen, Germany). During his career, he focused on the delivery of multiple RNA modalities...

Benjamin Damien is an innovative player and seasoned professional in the biotech industry, currently serving as the CEO of Sagitta Biotech.With over 22 years of experience in research, development, and strategic partnering within the global vaccine industry, Benjamin has a proven track record of...

Dr. Kashmira Date is a physician, epidemiologist and global health leader with over 20 years of experience and leadership in the public and private sector with clinical development/medical/scientific affairs in infectious diseases, vaccines, epidemiology, real-world evidence, pandemic...

Ilse De Coster is heading the Ambulatory Clinical Trial Unit of the Center for the Evaluation of Vaccination, a research center specialized in conduct of clinical vaccine trials at Vaccinopolis, University of Antwerp in Belgium. She obtained her MD as general practitioner in 1993.  Following...

Marien de Jonge is Full Professor of Infection and Immunity and Head of the Laboratory of Medical Immunology at Radboud University Medical Center in Nijmegen, The Netherlands. He obtained a PhD from the University of Amsterdam in 2003, followed by a postdoctoral fellowship at the Institut Pasteur...

Dr. de Jongh has a M.Sc. in Chemical Engineering from the University of Stellenbosch, South Africa and was awarded a doctorate in Biotechnology from the Technical University of Denmark (DTU). Furthermore, he was awarded an affiliated associate professorship at DTU in 2017. Dr. de Jongh has 18years...

Professor Mary De Silva is  Deputy Chief Scientific Adviser in the Department of Health and Social Care (DHSC), responsible for broad scientific areas including health protection, innovation and cross government science policy.  Mary is also Head of the Science and Engineering Profession in...

Ingrid de Visser - Kamerling (1975) graduated in Medical Biology from Leiden University in 1998. She subsequently worked at CHDR as a project leader and PhD student. She obtained her PhD from Leiden University in 2003 and became a registered clinical pharmacologist in 2005. From 2004 to 2007, she...

After obtaining a M.Sc. and Ph.D in Immunology and a period working in vaccine research, Andrew Deavin has spent the past 30 years in Regulatory Affairs covering UK, Europe and International. He has managed regulatory projects in development, registration and life-cycle primarily in vaccines but...

Dimitri Diavatopoulos is Associate Professor at the Laboratory of Medical Immunology and a member of the Radboud Community for Infectious Diseases at Radboud University Medical Center in the Netherlands. He studied Bioprocess Engineering at Wageningen University and obtained his PhD at Utrecht...

Julia Djonova, MD is Head of the Advanced Therapy Medicinal Products (ATMP) department at Swissmedic, the Swiss Agency for Therapeutic Products. Dr Djonova is a medical doctor trained in cardiology, followed by academic and research roles at the Universities of Lausanne and Fribourg in...

Valentino D'Onofrio obtained his PhD at Hasselt University (Belgium) and Radboud University (The Netherlands) where he focused on the innate immune mechanisms and host response to infections in sepsis patients. Currently, he is a postdoctoral researcher at the Center for Vaccinology at Ghent...

​​​​​​​Dr. Kyle Doolan leads cross-functional teams in molecular biology, protein engineering and virology that perform experiments for operations and research and development. Kyle has been instrumental in enhancing the performance of Integral Molecular’s technologies and is an inventor on two of...

Helge Dorfmuller is a Principal Investigator at the University of Dundee, dedicated to advancing research and development in vaccines. With expertise in structural glycobiology and infectious diseases, he and his team explore the pathways responsible for generating bacterial surface...

Sandy trained clinically as a pharmaceutical physician. He leads a research group at the University of Oxford with interests in vaccine manufacturing and in translational development of novel vaccines, including against rabies & Epstein Barr virus

Managing Partner and Consultant at GreyRigge Associates with experience spanning over 20 years’ working for Biopharmaceutical Companies including GlaxoSmithKline, Ipsen Biopharma, Lonza and Emergent Biosolutions. Skills Include: Expertise in analytical development activitiesCMC project...

Ruxandra Draghia-Akli, MD, PhD Executive Vice President, Head of Research & Development, Novavax Ruxandra Draghia-Akli, MD, PhD, is the Executive Vice President and Head of Research & Development (R&D) with the responsibility of evaluating opportunities for our early and late-stage...

Rosybel Drury is a seasoned professional with over 20 years of experience in the pharmaceutical industry, currently serving as the Senior Director of Global Medical & Scientific Affairs at MSD. With a strong background in research, development, and strategic partnering, Rosybel has a proven...

Carel du Marchie Sarvaas is Executive Director of HealthforAnimals, the global animal health association. HealthforAnimals represents the top 10 global animal health companies developing and manufacturing veterinary vaccines, parasite control products, diagnostics, antibiotics, digital...

Prof. Andrej Egorov received his MD and PhD in St. Petersburg, Russia. The initial topic of his carrier was the research and development of the live cold-adapted attenuated influenza vaccines. From 1996 he has been working as a Professor at the Institute of Applied Microbiology in...

Mark A. Emalfarb is the founder of Dyadic, and currently serves as the Chief Executive Officer and a member of the Board of Directors of the Company. He has been a member of Dyadic’s board of directors and has previously served as its Chairman from October 2004 until April 2007 and from June 2008...

An immunologist specializing in immunotherapies and vaccinology, Mathieu Epardaud joined the BioMAP team of the UMR ISP 1282 University – INRAE in 2018 to contribute to the development of mucosal vaccine platform strategies. He previously contributed to research on (1) preclinical models for the...

Nicola Esposito is an experienced CMC expert with a strong background in biopharmaceutical quality systems, new drug development, clinical biochemistry, and medical biotechnology. He earned his second-level degree in Molecular Biology and completed a PhD in Medical Biotechnology at the University...

Gonçalo Farias is currently working as a Laboratory Manager for Nasal and Innovation Services at Aptar Pharma (France). He holds an MSc in Pharmaceutical Sciences from the University of Lisbon, Portugal (2014), and a Ph.D. in Pharmacy & Pharmacology from the University of Bath, UK...

Dr. Jonathan A. Fauerbach, PhD, MBAHead of R&D, LenioBio GmbH Jonathan Fauerbach is Head of Research and Development at LenioBio, where he leads the advancement of ALiCE®, a next-generation eukaryotic cell-free protein expression platform designed to transform the pace and possibilities of...

Dr Findlow obtained a Bachelor of Science (Honours) in Molecular and Cellular Biology, graduating in 2000. He subsequently joined the Vaccine Evaluation Unit (VEU) at the Public Health Laboratory Service in Manchester, UK, where he served as a Clinical Scientist focusing on the serological...

Dr Joe Fitchett is Senior Adviser for Biotechnology at the Institut Pasteur de Dakar, Senegal.In this role, Joe is responsible for the IPD vaccine pipeline and oversees the strategy to launch new capabilities for the development and production of regionally-relevant countermeasures for epidemics as ...

Tom has spent his career building data analysis solutions and scaling teams to tackle cybersecurity, financial crime, and terrorist threats. He co-founded Refute to address the next critical threat to commercial organisations: disinformation. At Refute, Tom and his team help organisations detect...

Mark J. Geels, PhD is a senior biotechnology executive with over two decades of experience in vaccine development, translational science, and strategic program leadership. He currently serves as Senior Director at IAVI, where he coordinates transversal efforts across the organization’s Discovery...

​​​​​​​Dr. Christina K. Go earned her Ph.D. in Biomedical Sciences from the Lewis Katz School of Medicine at Temple University studying membrane protein interactions in T cell activation. Following her dissertation, she completed a research fellowship at the University of Pennsylvania in immunology ...

Edward Grahame is the Nanomedicine Alliance Manager for Europe at Cytiva, where he focuses on advancing Cytiva’s LNP platform and drug development services in collaboration with biopharma partners across the region.  He brings over 10 years of experience in nanomedicine and vaccine development. He ...

Christopher Green is a Professor and Consultant Physician in Infectious Diseases & Global Health. As well as being a front-line NHS clinician, his main work and research interests focus on the development of new experimental vaccines for infectious diseases and in optimising vaccine impact in...

Professor of Tropical Medicine and Traveller Medicine at the University of Amsterdam, Martin Peter Grobusch leads the Center for Tropical Medicine and Travel Medicine at Amsterdam UMC. A specialist in internal medicine, infectious diseases, and tropical medicine since 2000, he combines clinical...

Vice President and Head of Emerging Infectious Diseases and Epidemiology Swati Gupta, DrPH, MPH, leads IAVI’s Emerging Infectious Disease product portfolio and the development of the organization’s overall scientific strategy. She has a particular focus in leveraging IAVI’s recombinant vesicular...

Prof. Carlos A. Guzmán (MD, PhD) is head of the department Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection Research and also APL professor at the Hannover Medical School.He studied Medicine at the National University of Rosario and received his specialization in Medical...

My research line focusses on the pathogenesis of viral infections and especially those viruses that emerge through zoonotic transmission. This brings together work performed earlier at the Veterinary faculty in Utrecht and more recent work on human viruses in Rotterdam.  We have characterised the...

Dirk Hahneiser is a seasoned executive with over 25 years of experience in the medtech, biotechnology and pharmaceutical industries. As the Chief Commercial Officer at Cocoon Bioscience, Dirk is responsible for driving the company's commercial strategy and partnerships in the global enzyme...

Dr Bassam Hallis has over 25 years experience in scientific research including 15 years in regulated activities including vaccine evaluation, release/stability and clinical trial serology. He has extensive experience in assay development and validation including cell based and functional assays as...

Jonathan is an accomplished R&D and global public health professional with over 15 years of expertise in translational biologics, vaccine development, and infectious disease research. Currently serving as a Translational Science Lead at the Francis Crick Institute, he plays a pivotal role in...

Jonathan Heeney has had a distinguished career in the vaccine research and development. As Professor at the University of Cambridge he has headed the Lab of Viral Zoonotics he has made seminal contributions to understanding the immune correlates of immune protection to guide the development of...

Currently, I am Global Lead Clinical Immunology in Clinical development at CEPI, the Coalition for Epidemic Preparedness Innovations. I focus on generating the data at the required quality level that will support the development of vaccines for pathogens of pandemic potential. Before that, I was...

Parasites cause some of the most deadly diseases to affect humans. Malaria is the most devastating of these, and is responsible for hundreds of millions of cases each year, with hundreds of thousands of deaths. In order to survive within our bodies, parasites must interact with the molecules of our ...

Rico Hinrichs is an expert in the analytical development group at IDT Biologika, holding a bachelor’s degree in biotechnology. With more than 9 years of hands-on experience, he has built deep expertise in advanced and specialized technologies. His work focuses on PCR technologies...

Catherine Hoath is the Global Regulatory Affairs Strategy Lead for CEPI, where she is responsible for driving regulatory innovations to accelerate vaccine development as well as CEPI's platform technology strategy in support of the 100 days mission. She leads an industry focused regulatory...

Kee-Jong Hong (BS, Seoul National Univ; MS, Seoul National Univ; PhD, Texas Tech Univ) is currently a Professor at the Department of the Microbiology, Gachon University School of Medicine, Korea, and a Program Manager of Division for Health Security at Korea Advanced Research Project Agency for...

Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and nanotechnology to understand receptor trafficking. He...

Jayasree K. Iyer is the CEO of the Access to Medicine Foundation, where she leads its mission to drive change in global healthcare by engaging pharmaceutical companies to expand access to essential medicines in low- and middle-income countries. With expertise in addressing complex issues like drug...

Mark Jit is the inaugural chair and a professor in the Department of Global and Environmental Health. He was formerly head of the Department of Infectious Disease Epidemiology & Dynamics and co-director of the Global Health Economics Centre (GHECO) at the London School of Hygiene & Tropical ...

Dr. Janet K. Yamamoto is currently a professor of immunology and virology in the Department of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine at the University of Florida. She received her Ph.D. in immunology with a minor in virology from the University of Texas...

Dr. Erta Kalanxhi is a Fellow and Director of Partnerships at the One Health Trust, where she leads initiatives that highlight the vital role vaccines play in addressing the problem of drug-resistant infections. With a background in science and extensive experience in global health...

Gaurav is a Biotech professional with over a decade of experience in vaccine development and global public health. At CEPI, he leads Business Development and Strategic management for the priority pathogen vaccine portfolios, supporting collaborations, Partnerships, and Equitable Access...

Juhienah Khalaf is a medicinal chemist specializing in the design, synthesis, and development of bioactive compounds, including small-molecule immunomodulatory and protease inhibitors. With a strong foundation in medicinal and organic chemistry, she has advanced research on therapeutic molecules...

Dr. Asfandyar Khattak is a public health physician with over nine years of experience with the World Health Organization, specializing in immunization and vaccine-preventable disease (VPD) surveillance in low-resource and high-risk settings. He has played a pivotal role in...

Younbeen Kim is a pharmacist and life science executive with over 25 years of experience in thepharmaceutical industry, venture investment, and global health R&D. She previously served asHead of Research Operations & Global Partnerships at the Novartis Institute for TropicalDiseases in...

Alasdair King qualified as a veterinary surgeon from Glasgow University in 1990.  After 11 years in mixed practice he joined Intervet UK as livestock veterinary advisor.  Amongst other roles in the UK, he took on responsibility for company pharmacovigilance as the National PV Manager, and developed ...

Dr. Zoltán Kis is a Senior Lecturer (Associate Professor) at the Department of Chemical and Biological Engineering at The University of Sheffield, and an Honorary Lecturer at the Department of Chemical Engineering, Imperial College London.Zoltán is leading a multidisciplinary team that is...

​​​​​​Dr Jelle Klein graduated as Medical Doctor in 2016 from the University of Antwerp with a Master of Science in Medicine. Prior to this, he received a Bachelor of Health from the Hanzehogeschool in Groningen in 2009. In 2024 he was board-certified as a specialist in Clinical Pharmacology and...

Hester Kuipers leads the IAVI European office and Netherlands-registered foundation, overseeing the External Affairs program, encompassing advocacy, policy, communications and resource mobilization. She helps drive organizational strategies and financial sustainability initiatives as a member of...

Marc is the global head for CSL Seqirus Pandemic & Outbreak, leading the cross functional team in Pandemic preparedness and response, including the development of strategy and commercialisation for the CSL Seqirus pandemic portfolio.  Marc's experience includes 34 years in global...

Dr. Jose M. Lagaron is a Full Professor, Founder, and Group Leader of the Novel Materials and Nanotechnology for Health Applications group at CSIC (Spanish National Research Council). He also serves as CEO and CSO of BIONANOPHARMA S.L. According to Scopus, Dr. Lagaron has authored 373 peer-reviewed ...

Mr Lake has worked in vaccine manufacturing and commercialization for 30years, developing diverse experience at global leaders Merck and GlaxoSmithKline. Mr Lake's background includes live virus and recombinant vaccine bulk production, sterile filling, and quality control, before moving into...

Professor Teresa Lambe is the Calleva Head of Vaccine Immunology and a Professor of Vaccinology & Immunology and PSI Investigator  at the University of Oxford. She is leading a research group which improves human health by controlling disease through vaccination – stopping epidemics before they ...

Director, Biomedical Primate Research Centre (BPRC), the Netherlands Merel Langelaar is a veterinarian, immunologist, and senior public health expert with a career spanning over 25 years across science, policy, and governance. Since 2024, she has served as Director of the Biomedical Primate...

Alexandre Le Vert is the Executive Chairman and Co-Founder of Osivax. Alexandre is a serial entrepreneur with a fascination for biology and more than 20 years of experience in healthcare ranging from research and development to commercialization of vaccines and therapeutics.He has led several...

Lennard is an accomplished Oxford University cancer physician and national senior advisor for the cancer vaccine advance in the UK, and chief medical officer at the Ellison Institute of Technology. He is a research scene setter with a successful track record in delivering strategic national health...

Je-Wook Lee is a Project Manager at the Korea Health Industry Development Institute (KHIDI), where he leads high-risk, high-reward R&D projects for the Korean ARPA-H Initiative. He specializes in addressing critical health security challenges by advancing novel medical countermeasures through...

Darren holds a PhD in microbiology from Trinity College Dublin, where he also did his BA in microbiology. He spent a three year post-doc in the Jenner Institute at the University of Oxford developing vaccines against infectious diseases. He is an experienced team and project leader in both start-up ...

Geert Leroux-Roels obtained the MD degree from the Ghent University in 1976. He completed a specialty training in internal medicine and conducted doctoral research in clinical pathology and immunology. In 1981 he was board certified in internal medicine and a obtained a PhD degree in biomedical...

Maja Leskovec holds a degree in Ecology from the University of Nova Gorica. Transitioning from her academic background, she started a career in the gene therapy sector, where she has made contributions to downstream processing of viral vectors and vaccines. Maja has held roles including Associate...

Dr. Ofer Levy is principal investigator, staff physician and the Director of the Precision Vaccines Program at Boston Children’s Hospital, Professor of Pediatrics at Harvard Medical School, and Associate Member of the Broad Institute of MIT and Harvard. The Precision Vaccines Program (PVP) is an...

I qualified in Medicine from the University of Oxford in 1980.  After working around the UK in hospital medicine and research, I joined the pharmaceutical industry in 1986.  I am a Fellow of the Faculty of Pharmaceutical Medicine and a Fellow of the Academy of Medical Sciences. For over 30 years I...

Dr. Mats Lundgren is a leading authority in vaccine discovery and development, with over 30 years of experience in the biopharmaceutical industry. His diverse background encompasses a wide range of roles, from scientist to vice president, equipping him with a thorough understanding of the...

Angela Luttick is a virologist with more than 20 years’ experience in the discovery, development and commercialisation of novel drugs. Well accustomed to leading multidisciplinary teams and experienced in the generation and integrity of key discovery-stage biological data required for the...

Prof. Kirsten Maertens is affiliated with the Centre for the Evaluation of Vaccination located at Vaccinopolis, University of Antwerp. Prof. Maertens is conducting research on different aspects of vaccination in pregnancy. Her comprehensive research portfolio includes a wide spectrum of research...

Leonardo earned his PhD in Biotechnology in 2011 through a collaboration with the Carnegie Institution for Science at Stanford University, followed by experience as an Alexander von Humboldt postdoctoral fellow and Research Scientist. In 2016, he joined Ingenza, where he now serves as Vice...

Dr. Alessandro Manenti graduated in Biology in 2009 obtained the Ph.D in Molecular Biology in 2016 at the University of Siena. From 2016 to 2020 he worked as a Project Director in VisMederi managing the R&D department involved in the set-up, development and standardization of new serological...

Dr. Gerben Marsman obtained his doctorate degree at Sanquin Research (Amsterdam, The Netherlands) and completed a post-doctoral research position at the Max-Planck Institute for Infection Biology (Berlin, Germany). He joined the VFI in 2023 as a Project Manager and is currently Head of Alliance...

Pietro Mastroeni is the Professor of Infection and Immunity at the University of Cambridge, United Kingdom, with a proven track record of groundbreaking research in the field of host-pathogen interaction, immunology, infectious diseases, antimicrobials and vaccines.  He obtained a Medical Degree...

Mr. Mazzei has over 25 years of experience in clinical research within the pharmaceutical life sciences industry. He joined PPD in February 2005 and currently serves as project oversight director for vaccines, managing a portfolio of Phase I-III studies to ensure delivery, compliance, and...

I am currently Clinical Science Director at Johnson & Johnson, where I am accountable for clinical efficacy and immunogenicity data for the global ExPEC vaccine program. Prior to that, I was the Compound Development Team Lead for the Johnson & Johnson Global Universal Flu vaccine, and the...

Dr. Mesaros serves as vice president in the medical science & strategy group of the PPD clinical research business of Thermo Fisher Scientific. She joined the company after spending more than 16 years in the pharmaceutical industry. During her tenure with GSK and Janssen (J&J), Narcisa...

Pierre A. MORGON is a life science entrepreneur, co-founder of companies, and advisor to venture capital and private equity funds. He also holds several board positions in private and public emerging ventures and non-profit organizations.   Pierre has over 35 years of experience in the global...

Matthias graduated from the University of Vienna in the field of virology and molecular biology. In 2011 he joined Themis Bioscience, a biotech start-up specialized in the development of vaccines against emerging infectious diseases. At Themis he established the Technical Operations Department and...

Dr Ankur Mutreja, PhD, FRSB is currently a Director of External Affairs and Health Security at PATH operating from the UK and India. An experienced global health professional who has worked in industry, academia and public health, Dr Mutreja has significant expertise in R&D...

Personal Statement I am a Professor of Infectious Diseases and Senior Principal Clinical Research Scientist at the Kenya Medical Research Institute (KEMRI). My training includes Medicine and Surgery (University of Nairobi), Tropical Medicine (Nagasaki University) and Clinical Medicine...

Mihai Netea was born and studied medicine in Cluj-Napoca, Romania. He completed his PhD at the Radboud University Nijmegen, The Netherlands, on studies investigating the cytokine network in sepsis. After working as a post-doc at the University of Colorado, he returned to Nijmegen where he finished...

  Mark Newman, PhD, has 35 years’ experience in the biotechnology sector serving in senior management roles at GeoVax (Atlanta, GA), PaxVax (San Diego, CA), Pharmexa (Horsholm, Denmark), Epimmune (San Diego, CA), Vaxcel (Atlanta, GA), Apollon (Philadelphia, PA) and Cambridge Biotech (Boston, MA)...

Hanna Nohynek is Professor MD PhD, with special competences in vaccinology, international and travel health (FMA); Chief Physician Unit Prevention of Health Threats of Department of Public Health in Finnish Institute for Health and Welfare (THL), a governmental research agency. She was...

Dr. Karen O’Hanlon has worked in drug development for over 20 years and has a wealth of experience in vaccine development and clinical operations leadership. As Chief Development Officer at Stablepharma, she plays a pivotal role in advancing the Company’s mission to create fridge-free, thermostable ...

Senior biopharmaceutical expert with extensive experience in the development of biological products.  Rod demonstrates proven expertise across diverse biopharmaceutical disciplines, including regulatory experience and authoring CMC sections for clinical trials and commercial registrations.   Rod...

Albert Osterhaus is one of the world's leading virologists and his group was the first to identify human infection with the avian influenza strain H5N1. After qualifying as a veterinarian, Albert Osterhaus moved into research and graduated from Utrecht University in his native Netherlands in...

James trained as a chemist and holds a master’s degree in spectroscopy and a doctorate in pharmaceutical chemistry. Today he is based in the United Kingdom as an established senior director in the regulatory group within the PPD clinical research business of Thermo Fisher Scientific.  His career in ...

Heenal Patel is the Head of Strategic Partnerships at Paratus Clinical Research, bringing over 15 years of experience in healthcare with a strong background in clinical nutrition and medical science. Holding degrees from New South Wales, Australia, she transitioned into clinical research four years ...

Short Narrative bio: Sandeep is the CEO of Humanity Health Ventures, a venture studio creating and supporting new categories of companies unlocking health for everyone. He was the inaugural Director of BARDA’s Division of Research, Innovation, and Ventures (DRIVe), within the U.S. Dept. of Health...

Lineke Pelleboer holds a Bachelor’s degree in Medical Research and Biotechnology and an Executive MBA in change management. With more than 20 years in the pharmaceutical and biotech industry, she has led technology transfer projects from every perspective: as project lead, as head of manufacturing...

Elise Pepermans obtained her PhD in Biochemistry in the Pasteur Institut in Paris. During her post-doc in the Center for Proteomics (University of Antwerp/Flemish Institut for Technological Research) she developed an optimized workflow for advanced immunopeptidomics. Since March 2023, she is one of ...

Umberto Perron, PhD, is a Senior Computational Biologist with 10 years of research experience in academia and the techbio industry. He has a background in molecular biology and bioinformatics with a MSc in Molecular Biotechnology (2016) and a BSc in Biotechnology (2014), both from the Università...

Tim Peterson is the Scientific Director, Dermal Drug Delivery for Kindeva Drug Delivery in Woodbury, MN.  He has over 35 years experience developing complex drug/device combination products and processes, including transdermal patches and microneedle systems for intradermal delivery of drugs and...

Dr. Katrien Poelaert is a veterinarian by training and obtained her PhD in Veterinary Sciences in 2019 at the Laboratory of Virology, Faculty of Veterinary Medicine (Ghent University, Belgium) under the supervision of Prof. Nauwynck, focussing on the pathogenesis of equine herpes viruses. She was...

Dr. Jan Poolman is former Head Bacterial Vaccine Discovery and Early Development at Janssen Infectious Diseases and Vaccines, at the Janssen Pharmaceutical Companies of Johnson & Johnson. Jan leads the bacterial vaccines team, which focuses on developing vaccines against the most prevalent...

Prof Maarten J Postma (29/01/1960) holds the chair Global Health Economics at the University Medical Center Groningen (UMCG) and the faculty of Economics & Business, both at the University of Groningen. Also, he is Prof in Pharmacoeconomics at the Departments of Pharmacy at the University of...

Dr. Philip Probert is a strategic scientific leader with extensive experience in bioprocessing and strategy development. He currently serves as Biologics Technology Lead at CPI, where he heads up the development department, delivering a diverse portfolio of innovation projects focused on the...

With more than 15 years of commercial experience in the global Life Sciences industry, Kimberley brings deep expertise in biosafety testing for Cell and Gene Therapy (CGT), Biologics, and Vaccine manufacturing. As the Business Development Manager at PathoQuest SAS, she leads partnerships across the ...

Dr. Reda Rawi is a Staff Scientist and Head of the Structural Bioinformatics Core at the NIH Vaccine Research Center (VRC). He holds a Diploma in Mathematics from the University of Applied Sciences Koblenz (2007), an MSc in Bioinformatics from Birkbeck, University of London (2008), and a PhD in...

Dr. Xiaozhi Ren is the Director of CMC at WuXi Vaccines. He earned his Ph.D. from China Agricultural University and completed his postdoctoral training at Johns Hopkins University. Dr. Ren began his industry career at Sanofi, specializing in cell line development, before moving on to roles at...

Giovanna Riggall is a seasoned professional with over 15 years of experience in the healthcare industry, specializing in health supply chain management. Currently serving as the Head of Health Supply Chain at Unimed, Giovanna is a strategic leader known for her innovative approaches to optimizing...

Ruben Rizzi, physician by training, SVP of Global Regulatory Affairs at BioNTech. I joined the company in December 2019 just before the pandemic, and I have been the global regulatory lead for BioNTech for our COVID-19 development. Currently, I am still supporting the lifecycle of our COVID-19...

Mario Rodriguez is a seasoned professional with over 25 years of experience in the biopharmaceutical industry, currently serving as the Senior Director for Medical Counter Measures in the Global Medical Affairs team at Emergent BioSolutions. With a strong background in research, development, and...

Meta Roestenberg is an infectious diseases clinician at Leiden University Medical Center in the Netherlands  where she leads a group of translational researchers in answering key questions related to host-pathogen interaction by making use of controlled human infection models. Her team pioneered...

Professor Paul Rolan is a specialist internal medicine and pharmaceutical physician. He has extensive experience in the early development of new medicines across a broad range of therapeutic areas. He has been principal investigator in over 750 clinical studies and had been in clinical practice for ...

Ysaline ROLAND, MSc, Head of Bioprocess Department at Naobios, since december 2025, is in charge of planning and execution of process development and clinical manufacturing activities for virus-based products at lab, pilot and manufacturing scale. Previously she was Head of Production. Thanks to...

Dr. Romanik is the Distinguished Senior Fellow in Global Health Security at Brown University School of Public Health, who most recently served as the Special Assistant to the President, Deputy Director, and Chief of Staff for the Office of Pandemic Preparedness and Response Policy (OPPR) at the...

Simona Rondini is the Head of Bacterial Vaccine Development and Senior Project leader at GSK Vaccines Institute for Global Health (GVGH) in Siena (Italy). Simona holds a PhD in Microbiology awarded by the Swiss Tropical Public Health Institute in Basel, and conducted postdoctoral studies at the...

Morten Ruhwald is a seasoned healthcare executive with a strong background in medical affairs and strategic leadership. Currently serving as the Chief Medical Officer at Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI-D), Morten is a  medical Doctor with extensive scientific...

Dr. Milla Runsala earned her Doctorate from the University of Turku, where she researched immune responses. She currently serves as a Business Development Manager, focusing on exploring new opportunities for sustained drug therapies using Silica Matrix drug delivery technology. Recently, DelSiTech...

Dr. Jerald Sadoff, M.D. as Chief Medical Officer with immediate effect. Dr. Sadoff has more than fifty years of experience in vaccine development. He has overseen or played a key role in the approval of more vaccines than any other currently active vaccine developer, including vaccines against...

A veterinarian by training, after completing my PhD at The Pirbright Institute in 1993 I became Head of the International FMD Vaccine Bank and held the position for 4 years. I moved to Pfizer AH in Sandwich, England in 1997 and eventually became Director of Biologicals Research for Europe, Africa...

Merijn Salverda has been working as a Scientist Bacterial Vaccines at Intravacc for well over a decade. He obtained his PhD at Wageningen University in the Netherlands, studying the experimental evolution of antibiotic resistance. At Intravacc, his work has focused on the genetic engineering of...

Tyler Sandberg is a scientist holding a PhD in vaccine immunology from the Karolinska Institute and a master’s degree in immunology and infection biology from Uppsala University.His doctoral research involved conducting several vaccine studies to examine human immune responses to various flavivirus ...

Melanie Saville, MBBS, is PATH’s Chief Scientific Officer. She leads PATH’s product development division, which includes a global team dedicated to the development, introduction, and scale of vaccines, medical devices, and diagnostics. Dr. Saville is a distinguished physician specializing in...

Hanneke Schuitemaker, Ph.D., is the Chief Scientific Officer at Valneva, Austria, with responsibility for pre-clinical and translational R&D for prophylactic vaccines against Chikungunya, Lyme disease, Zika, Shigella, EBV and ETEC. Before joining Valneva, she served for almost 14 years as the...

George Simeon is the CEO of Curevo Vaccine. He joined Curevo at the beginning of 2019 and has over 30 years of experience in the healthcare sector working with multinational firms, start-ups, and not-for-profits. He has worked in biotech, vaccines, pharmaceuticals, medical devices, IVD, and...

Co-founder and Chief Executive Officer of Scandinavian Biopharma. Björn is former Chief Executive Officer of UniTech Pharma AB (2010-2011), Chief Business Officer of Crucell (2006-2009), a Dutch former listed company with facilities in the Netherlands, Switzerland and USA specializing in vaccines...

Mads Skovvang is a seasoned professional in healthcare logistics, currently serving as the Manager of Commercial Supply Chain for Europe at World Courier. With over 10 years of experience in pharmaceutical transport and third-party logistics (3PL) services, he has developed his expertise in...

Igor Smolenov is the Chief Development Officer of Arcturus Therapeutics. Dr. Smolenov is an infectious disease physician dedicated to the clinical development of novel vaccines, with a proven record of accomplishment in both small biotechnology and large pharmaceutical companies. He contributed to...

Marco Soriani, is a cellular microbiologist with more than 25 years in the field of infectious disease and vaccines. Currently, he acts as Project Director at Reithera (Rome, Italy), where he leads the Project Management Office. Regarding his scientific background, after qualifying in Biology at La ...

Bio: Prof. Lotte Steuten, PhD, is Deputy Chief Executive of the not-for-profit Office of Health Economics (OHE) and the scientific and business lead for its international research-led work program. Alongside her position at OHE, Lotte is a Visiting Honorary Professor at City University of...

Jeffrey Stolwijk is a cell biologist and toxicologist with deep expertise in oncology, immunology, and translational science. As Scientific Director at Uneedle, he plays a central role in advancing clinical programs in collaboration with Uneedle's pharmaceutical and biotech partners. His work...

I am Clinical Science Director in the Clinical Microbiology and Immunology department at Johnson & Johnson. I have contributed to various viral and bacterial vaccine programs as a bioanalytical specialist and team supervisor, leading a group of bioanalytical experts. My expertise lies in the...

Walter Straus is Vice President and Distinguished Vaccine Safety Physician at Moderna, where he oversees vaccine safety for the company’s vaccine pipeline. Prior to joining Moderna, Dr. Straus was an Epidemic Intelligence Officer before joining the permanent staff at the Centers for Disease Control ...

Dr. Sumner leads INOVIO’s clinical-stage pipeline of DNA medicines. Dr. Sumner previously served as CMO of Orexo AB and held numerous European- and US-based leadership roles at Novartis Pharmaceuticals, Aventis Behring, Novo Nordisk and Shire Pharmaceuticals. Dr. Sumner brings over 30 years of...

Miriam Taegtmeyer is a Professor of Global Health at the Liverpool School of Tropical Medicine, where she heads the Community Health Systems Research Group.  The group consists of staff and doctoral students with a research portfolio of over £8 million (2018), spanning 11 countries across Africa...

Originally from Finland, Anna holds a master's degree in cell biology and years of experience in pharmaceutical in-vitro research as well as bioprocessing solutions.She's currently employed as a field application specialist for Novo Nordisk Pharmatech located in Denmark. Her role is to act...

Dr Tan is a Principal Investigator at the MRC Translational Immune Discovery Unit.  His research focuses developing next-generation protein nanoparticle-based vaccines and antibody therapeutics against infectious diseases. He is particularly interested in understanding how the architecture of...

Hamid Trimech is a Process Engineer with over 10 years of experience in GMP facility construction, technology transfers and vaccine manufacturing. He is currently Project Manager in Business Development at ARCALIS Inc., a Japan-based CDMO specialized in mRNA therapeutics and vaccines. Hamid began...

Thomas is Director of Bioinformatics and AI/ML at Evaxion, where he leads the development of Evaxion’s AI-Immunology™ platform for designing vaccines against cancer and infectious diseases. Prior to joining Evaxion in 2016, Thomas acquired his PhD in Immunological Bioinformatics from the Technical...

Dr. Tucker completed his doctoral degree in Immunology at the University of Washington. Dr. Tucker is the Chief Scientific Officer and Vice President for Research at Vaxart, Inc, a company focused on mucosal vaccine delivery. He has published several papers in immunology and served as a grant...

Ola TuvessonChief Technology OfficerAs CTO, Ola is leading NorthX Biologic’s development and project organization, focusing on delivering technologies and strategies to ensure high-end services within bioprocessing and analytics. He has more than 20 years’ experience from the pharma and biotech...

Sebastian Ulbert is a molecular biologist and lecturer in virology. He is the Deputy Director of the Fraunhofer Institute for Cell Therapy and Immunology and the Head of the Department for Vaccines and Infection Models. The Fraunhofer Society is Europe's largest application-oriented research...

When you're sick, you only want one thing: to get better. So why not stay healthy when you can? After all, according to an old Dutch saying: 'prevention is better than cure'. For years and years, biotech has helped us cure and prevent (infectious) diseases. Yet in our current healthcare ...

Nina van Sorge is Professor of Translational Microbiology at the Department of Medical Microbiology and Infection Prevention at Amsterdam UMC, The Netherlands. Her research is aimed at clarifying the molecular pathogenesis of bacterial infections with respect to innate recognition and...

Nico Vandaele (PhD in Business Engineering, Operations Management and Operations Research, 1996) is full professor at KU Leuven since 2007, teaching courses in operations research, operations management, supply chain management and health systems design. Started with a research focus on...

Bruno Vandelanotte is a seasoned medical technology professional with more than 40 years of international experience in sales, business development, and market introduction of innovative medical devices. In his role as Sales Manager EMEA at Roncadelle Operations, he drives the commercialization of...

Dr. Veterinary Medicine, virologist, global networking in human and animal health, vaccines and diagnostics, global disease control, one health, public affairs with EU, WHO, Asian and African authorities and experienced in vaccine translational development.Achievements in brief: Discovery of H1N1...

Vanessa Vankerckhoven is Founder and CEO of Idevax, Belgian medical device company. She holds a PhD in Medical Sciences from the University of Antwerp, Belgium. She’s a passionate entrepreneur and also holds a position as Guest Professor at the Faculty of Medicine & Health Sciences at the...

Vijay Vaswani views technology as fundamental to humanity. He has been part of scaling companies such as Illumina and 10X Genomics. He has acquired and commercialized disruptive diagnostic technologies during his leadership at Siemens Healthineers and Meridian Biosciences. Vijay has been part of...

Roland Ventura holds a PhD in molecular biology and vaccines from the Queen’s University Belfast.  After postdoctoral training at the University of Oxford he worked with Dako A/S in Denmark under a European Commission-funded Marie Curie Transfer of Knowledge Fellowship.  Following this, he became...

Charlotte Vernhes is a bioengineer with 15 years of experience in vaccine research and development, spanning immunogenicity assessment, translational science and biomarker discovery, innovation management and public-private partnerships. Currently serving as Director of Scientific and Medical...

Thomas Verstraeten is the CEO and founder of P95, a global CRO at the forefront of vaccine and infectious disease research. A medical doctor and epidemiologist by training, Thomas is a recognized leader in global health innovation, with a career spanning over 25 years across...

Dr. Jenni Vuola is a Business Development Advisor for Rokote Laboratories Finland Oy. Jenni has a PhD in Microbiology and an Associate Professorship in Infection Research from the University of Helsinki, Finland. She did her post-doc research on malaria vaccine development in Prof. Adrian Hill’s...

Charlie Weller is Head of Vaccines in the Infectious Diseases Area at Wellcome. Since 2016, she led a team to develop new and improved vaccines & antibodies, gaining a better understanding of protective immunity and strengthening the connection between research and decision makers. Charlie...

Y. Tony Yang, ScD, LLM, MPH, is an endowed professor (with tenure) in health policy and Associate Dean for Health Policy and Population Science at George Washington University School of Nursing. He also holds a joint appointment at the Milken Institute School of Public Health in the Department of...